As. Ward et al., Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans, BEHAV PHARM, 9(7), 1998, pp. 577-586
Attenuation of hypothalamo pituitary-adrenal (HPA) function in laboratory r
odents has been found to reduce the reinforcing effects of cocaine. To exam
ine whether attenuation of HPA function reduces the effects of cocaine in h
umans, one female and seven male 'crack' cocaine abusers were pretreated wi
th three doses of ketoconazole (0, 600, 1200 mg), an inhibitor of adrenocor
ticoid biosynthesis, 1 h before receiving cocaine. Three doses of smoked co
caine (0, 12, 50 mg) were administered in counterbalanced order under each
ketoconazole condition. Ketoconazole dose-dependently reduced cocaine-induc
ed cortisol, but not adrenocorticotropin (ACTH) release, and attenuated the
cocaine-induced increase in heart rate and blood pressure. Plasma ACTH lev
els were more predictive of blood pressure changes than either cocaine or c
ortisol levels. Suppression of cortisol secretion was not associated with a
reduction in ratings of the subjective effects of cocaine. These results s
upport a role for the HPA axis in the cardiovascular effects of cocaine, bu
t do not support a role for the HPA axis in the subjective effects of cocai
ne. To the extent that self-administration can be predicted by subjective e
ffects, these results further argue that the HPA axis does not play a criti
cal role in cocaine self-administration by humans. Behav Pharmacol 1998; 9:
577-586 (C) 1998 Lippincott Williams & Wilkins.